News

Flightpath Biosciences, Inc is Selected to Participate in the Innovation Challenge at RESI Boston 2019

Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases

Dr. Rajadas to present at LymeMIND in NYC on October 19th, 2019

NEW
10-31-2019

S.1657, The Tick Act – LDA Letter to Committee on Health, Education, Welfare & Pensions

NEW
10-31-2019

Nicole Malachowski: Unfit for Duty from Debilitating Tick-Borne Disease

NEW
10-31-2019

Congressional Press Conf/#GivTue LymeAid4Kids/Another Powassan Death/NIH Strategic Plan/LDA Educates/IDSA Guidelines Critique

NEW
10-30-2019

LDA Educates Doctors & Public

NEW
10-26-2019

Rep. Chris Smith Press Conference on NIH/Tick Act, Wall, NJ

NEW
10-26-2019

Launch of a NEW group to improve Lyme identification and treatment